8
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Oroesophageal candidiasis is lethal for transgenic mice with combined natural killer and T-cell defects

, , , &
Pages 261-268 | Published online: 09 Jul 2009

References

  • Mehta SK, Stevens DA, Mishra SK, Feroze F, Pierson DL. Distribution of Candida albicans genotypes among family members. Diagn Microbiol Infect Dis 1999; 34: 19�25.
  • Odds FC. Candida and Candidosis: A Review and Bibliography. 2nd edn. London: Bailliere-Tindall, 1988.
  • Walsh TJ. Global expansion of nosocomial candidiasis. Int J Infect Dis 1997; 29: 19�24.
  • Green.eld RA, Abrams VL, Crawford DL, Kuhls TL. Effect of abrogation of natural killer cell activity on the course of candidiasis induced by intraperitoneal administration and gastrointestinal candidiasis in mice with severe combined immunode.ciency. Infect Immun 1993; 61: 2520�2525.
  • Pfaller MA. Epidemiology of candidiasis. J Hosp Infect 1995; 30:324�330.
  • Kao AS, Brandt ME, Pruitt WR, et al. The epidemiology of candidemia in two United States cities: Results of a populationbased active surveillance. Clin Infect Dis 1999; 29: 1164�1170.
  • Bodey GP. Candidiasis in cancer patients. Am J Med 1984; 77:13�19.
  • Georgopapadakou NH, Walsh TJ. Human mycoses: drugs and targets for emerging pathogens. Science 1994; 264: 371�373.
  • Walsh TJ, Hiemenz J, Pizzo PA. Editorial Response: Evolving risk factors for invasive fungal infections � All neutropenic patients are not the same. Clin Infect Dis 1994; 18: 793�798.
  • Edwards JE. Invasive Candida infections: evolution of a fungal pathogen. N Engl J Med 1991; 324: 1060�1062.
  • Darouiche RO. Oropharyngeal and esophageal candidiasis in immunocompromised patients: treatment issues. Clin Infect Dis1998; 26: 259�272.
  • McCarthy GM. Host factors associated with HIV-related oral candidiasis.A review. Oral Surg OralMed Oral Pathol 1992; 73:181�187.
  • Powderly WG, Landay A, Lederman MM. Recovery of the immune system with antiretroviral therapy. The end of opportunism? J Am Med Assoc 1998; 280: 72�77.
  • Rodriquez-Adrian LJ, Grazziutti ML, Rex JH, Anaissie EJ. The potential role of cytokine therapy for fungal infections in patients with cancer: is recovery from neutropenia all that is needed? Clin Infect Dis 1998; 26: 1270�1278.
  • Cantorna MT, Balish E. Mucosal and systemic candidiasis in congenitally immunode.cient mice. Infect Immun 1990; 58:1093�1100.
  • Cole GT, Lynn KT, Seshan KR. An animal model for oropharyngeal, esophageal and gastric candidosis. Mycoses1990; 33: 7�19.
  • Vazquez-Torres A, Jones-Carson J, Balish E. Nitric oxide production does not directly increase macrophage candidacidal activity. Infect Immun 1998; 63: 1142�1144.
  • Balish E, Filutowicz H. Serum antibody response of gnotobiotic athymic and euthymic mice following alimentary tract colonization and infection with Candida albicans. Can J Microbiol 1991;37: 204�210.
  • Balish E, FilutowiczH, Oberley TD. Correlates of cell-mediated immunity in Candida albicans-colonized gnotobiotic mice. Infect Immun 1990; 58: 107�113.
  • Balish E, Jensen J, Warner T, Brekke J, Leonard B. Mucosal and disseminated candidiasis in gnotobiotic SCID mice. J Med Vet Mycol 1993; 31: 143�154.
  • Jensen J, Balish E. Enhancement of susceptibility of CB-17 mice to systemic candidiasis by poly(I.C)-induced interferon. Infect Immun 1993; 61: 3530�3532.
  • Jensen J, Warner T, Balish E. Resistance of SCID mice to Candida albicans administered intravenously or colonizing the gut: Role of polymorphonuclear leukocytes and macrophages. J Infect Dis 1993; 167: 912�919.
  • Jensen J, Warner T, Balish E. The role of phagocytic cells in resistance to disseminated candidiasis in granulocytopenicmice. J Infect Dis 1994; 170: 900�905.
  • Wagner RD, Vazquez-Torres A, Jones-Carson J, Warner T, Balish E. B cell ��knockout�� mice are resistant to mucosal and systemic candidiasis of endogenous origin, but susceptible to experimental systemic candidiasis. J Infect Dis 1996; 174: 589�597.
  • Cole GT, Seshan KR, Lynn KT, Franco M. Gastrointestinal candidiasis: histopathology of Candida-host interactions in a murine model. Mycol Res 1993; 97: 385�408.
  • Cole GT, Saha K, Seshan KR, et al. Retrovirus-induced immunode.ciency in mice exacerbates gastrointestinal candidiasis. Infect Immun 1992; 60: 4168�4178.
  • Green.eld RA. Host defense system interactions with Candida. J Med Vet Mycol 1992; 30: 89�104.
  • Djeu JY, Blanchard DK. Regulation of human polymorphonuclear neutrophil (PMN) activity against Candida albicans by large granular lymphocytes via release of a PMN-activating factor. J Immunol 1987; 139: 2761�2767.
  • Vecchiarelli A, Bistoni F, Cenci E, Perito S, Cassone A. In-vitro killing of Candida species by murine immunoeffectors and its relationship to the experimental pathogenicity. Sabouraudia1985; 23: 377�387.
  • Zunino SJ, Hudig D. Interactions between human natural killer(NK) lymphocytes and yeast cells: human NK cells do not kill Candida albicans, although C. albicans blocks NK lysis of K562 cells. Infect Immun 1988; 56: 564�569.
  • Jensen J, Vazquez-Torres A, Balish E. Poly(I.C)-induced interferons enhance susceptibility of SCID mice to systemic candidiasis. Infect Immun 1992; 60: 4549�4557.
  • Romani L, Mencacci A, Cenci E, et al. Natural killer cells do not play a dominant role in CD4+ subset differentiation in Candida albicans-infected mice. Infect Immun 1993; 61: 3769�3774.
  • Jones-Carson J, Vazquez-Torres A, Balish E. Defective killing of Candida albicans hyphae by neutrophils from beige mice. J Infect Dis 1995; 171: 1664�1667.
  • Wang B, Biron C, She J, et al. A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene. Proc Natl Acad Sci USA 1994; 91: 9402�9406.
  • Balish E, Wagner RD, Vazquez-Torres A, et al. Mucosal and systemic candidiasis in IL-8Rh�/� BALB/c mice. J Leukoc Biol1999; 66: 144�150.
  • Wagner RD, Warner T, Pierson C, et al. Biotherapeutic effects of Bi.dobacterium spp. on orogastric and systemic candidiasis in immunode.cient mice. Rev Iberoamer Micol 1998; 15: 265�270.
  • Hestdal K, Ruscetti FW, Ihle JN, et al. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J Immunol 1991; 147: 22�27.
  • Wagner RD, Warner T, Pierson C, et al. Variable biotherapeutic effects of Lactobacillus acidophilus isolates on orogastric and systemic candidiasis in immunode.cient mice. Revista Iberoamericana de Micologia 1998; 15: 271�276.
  • Wagner RD, Warner T, Roberts L, Farmer J, Balish E. Colonization of congenitally immunode.cient mice with probiotic bacteria. Infect Immun 1997; 65: 3345�3351.
  • Bancroft GJ, Schreiber RD, Bosma GC, Bosma MJ, Unanue ER. A T cell-independentmechanism of macrophage activation by interferon-gamma. J Immunol 1987; 139: 1104�1107.
  • Cassatella MA. The production of cytokines by polymorphonuclear neutrophils. Immunol Today 1995; 16: 21�26.268 Balish et al.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.